mail
versión imprimible
 
 

4th Neuroimmunology Drug Development Summit

Evvnt Promotion / evvnt
-
18.04.2022 - 20.04.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 08:30 - 16:10
 
Temas de la conferencia
Since 2019, venture capitalists have been predicting a "golden era of neuroscience products" and successes of "radical new breakthrough therapies" in the notoriously challenging space.

Now, three years on, 2022 is hosting the neuroscience renaissance and pharma is doubling down to understand the neuropathological and neuroprotective role of neuroinflammation as the most promising opportunity to bring more targeted, precise and transformative therapies
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/956949-3?pid=4832

Speakers: Alejandro Rangel, Applied Neurosciences Department Head, Mexican Council of Neuroscience, Andrea Crotti, Principal Scientist, Takeda Pharmaceutical and more.
 

Información e inscripción:

https://go.evvnt.com/956949-2?pid=4832
Ms. Stephanie Nketia
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2999.0 - USD 5195.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichisches Rotes KreuzÄrzte der WeltAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Public Health Association (EUPHA)Center of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrztekammer für WienÖsterreichische Akademie der Ärzte